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ABSTRACT
Medicinal plants are being used all over the world for the prevention, treatment, and management of diseases. Most consumers assume that medicinal 
plants have no toxic effect because they are plant natural products. Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome 
coronavirus 2 which originated from Wuhan in China, is a current pandemic that is spreading globally. This disease has led to mortality of humans 
all over the world. There are reports from research that plants with antiviral, antioxidant, anti-inflammatory, or immunostimulatory activity might 
help in the treatment and prevention of this disease; and these have led to the increase in intake of medicinal plants with these activities all over the 
world. However, preclinical and clinical studies have not been carried out on some of these plants to confirm their use in prevention and treatment of 
COVID-19. Furthermore, the actual dose of some of these plant products for the prevention of the disease is unknown. This review discusses the use 
of medicinal plants including turmeric, garlic, and ginger for the treatment and prevention of COVID-19 and their possible toxic effects. In conclusion, 
medicinal plants should be taken in moderation in other to prevent adverse effects which include inflammation, nausea, vomiting, fever, and mortality.
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INTRODUCTION
Traditional systems of medicine have become a topic of global 
importance. The World Health Organization (WHO) reported that 80% 
of the world population use herbal medicine for their primary health 
care [1]. Although orthodox may be available in many developing and 
developed countries, people are still turning to traditional medicine 
practices that has to do with use of medicinal plants as herbs for the 
treatment of diseases [2]. This is due to the belief that medicinal plants 
have little or no side effects [3,4]. Plants with therapeutic effect have 
been used from ancient times for the treatment of diseases [5]. There 
are reports from the previous studies showing that medicinal plants 
have therapeutic properties which include anti-oxidant, anti-viral, anti-
cancer, and anti-inflammatory effects [6-10]. Medicinal plants exert 
these effects due to the presence of bioactive compounds which include 
gingerol, quercetin, and curcumin [11-13]. Emphasis has been placed 
on the use of medicinal plants for the treatment of diseases rather than 
prevention. However, there are reports from literature that medicinal 
plants can also be used for the prevention of diseases [6,7].
The novel coronavirus disease 2019 (COVID-19) is caused by severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [14] which 
is a member of beta coronaviruses family [15]. The outbreak of this 
virus occurred in December, 2019 in Wuhan, China [16]. This lead to 
the rapid spread of COVID-19 into a pandemic that is responsible for 
the recent health crisis globally [17]. SARS-CoV-2 is the seventh known 
virus of the Coronaviridae family that infects humans [18]. As at April 
10, 2021, there have been 135,568,565 confirmed cases of COVID-19 
and 2,932,845 deaths worldwide as reported by the WHO [11]. The 
United States of America has the highest number of COVID-19 cases 
(31,805,293 cases), followed by Brazil (13,375,414 cases) and India 
(13,261,376 cases) [19]. This disease spread fast by close contact 
with infected individuals through respiratory droplets from either 
coughing or sneezing [20]. COVID-19 exerts various symptoms which 
range from mild to severe among infected patients. The frequent 
manifestations of the disease reported by patients include fever (98%), 
cough (76%), fatigue (44%), sputum production (28%), and headache 
(8%) [21]. COVID-19 symptoms might also be accompanied by nasal 
congestion, runny nose, diarrhea, or sore throat. Fatal cases have also 
been reported by patients experiencing progressive respiratory failure 
due to SARS-CoV-2 attacking the alveolar epithelial cells [22,23]. This 
damage is caused by the receptor-binding domain attachment of the 
virus to the receptor on the respiratory tract in humans known as the 
angiotensin-converting enzyme-2 receptor [22] and transmembrane 
protease, serine 2 [23]. COVID-19 disease causes mortality in some 
cases due to acute respiratory distress syndrome and severe cytokine 
release syndrome [24]. The release of numerous pro-inflammatory 
cytokines in the blood is also responsible for the clinical appearance of 
inflammation in humans [21].
Researchers are trying to find a medicine for the treatment and 
prevention of COVID-19 because up to date there is no specific drug 
for the cure of the disease. There are reports that the immune status 
of patients plays an important role in COVID-19 infection [25]. Thus, 
studies are carried out on medicinal plants with immunostimulatory 
activities. There are reports from the literature that some plants with 
anti-viral effect also have the ability to boost the immune system [26]. 
Furthermore, there is a recent increase in the consumption of medicinal 
plants that have anti-viral, immunostimulatory, and anti-inflammatory 
effects by humans because of believe that plants with these activities 
have the ability to prevent or cure COVID-19 [11].
There is this believe by consumers that medicinal plants have no toxic 
effect or adverse effects because they are natural products. There are 
concerns regarding the use of medicinal plants and their ability to 
cause adverse effects which include nausea, vomiting, body itching, skin 
irritation, fever, and in severe cases death [27,28]. The WHO encourages 
the use of medicinal plants as supplements for health-care provided they 
are confirmed to be nontoxic [29]. Most medicinal plants consumers are 
ignorant of factors which include dosage and drug interactions that might 
lead to toxicity after intake of plants with medicinal activities [27,30].
This review highlights medicinal plants with immunostimulatory 
activity used for the prevention and treatment of COVID-19. The 
factors that might make medicinal plants to exert a toxic effect are also 
mentioned.
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Curcuma longa (turmeric)
It is a medicinal plant that belongs to the Zingiberaceae family and 
the genus Curcuma [31]. The rhizomes of C. longa are mostly used as 
spice, food flavor, and natural food coloring [32]. The plant is cultivated 
in all parts of the world. Turmeric is also used traditionally as food 
supplement and medicine [33]. There a reports from studies that 
turmeric has antioxidant, anti-inflammatory, antiviral, anticancer, and 
immunostimulatory activities [34]. C. longa is used as medicine for 
the treatment of diseases which include neurodegenerative diseases, 
diabetes, cardiovascular disease, asthma, inflammatory bowel disease, 
and high blood pressure [33,35]. Turmeric exerts these effects due 
to the presence of a bioactive compound known as curcumin [11]. 
Consuming high doses of turmeric over long period of time may cause 
stomach upset, skin rash, diarrhea, headache, and it might trigger 
miscarriage in women [36,37].
Allium sativum (garlic)
A. sativum commonly known as garlic belongs to the family Liliaceae and 
the genus Allium. The part of the plant used as spice and for medicinal 
purpose is the bulb. A. sativum is found all over the world. Studies have 
reported that garlic have anti-inflammatory, antioxidant, anti-fungal, 
antiviral, hypoglycemic, and immunostimulatory activities [38,39]. 
Garlic has also been used as spice in food and also in traditional 
medicine for the treatment of cough, cold, diabetes, hypertension, and 
asthma [38]. Allicin; a sulfur containing bioactive compound present in 
garlic is mainly responsible for the medicinal properties of garlic [40]. 
High doses of garlic have the ability to cause nausea, vomiting, diarrhea, 
and liver damage [41].
Zingiber officinale (GINGER)
The medicinal plant ginger with the botanical name Z. officinale also 
belongs to the family Zingiberaceae, genus Zingiber, and species 
officinale. The part of the plant used for medicinal purpose is the 
rhizome. Ginger is also found in all parts of the world. There are 
reports that ginger has antioxidant, anti-inflammatory, antiviral, 
immunostimulatory, and analgesic activities [42-44]. Ginger is used as 
food additive and for the treatment and prevention of diseases which 
include cancer, diabetes, cardiovascular diseases, asthma, cough, and 
inflammations due to the presence of a bioactive compound known 
as gingerol [13,45-48]. Ginger is generally considered to be safe [49]. 
However, the lack of complete understanding of its mechanism of action 
suggests caution when using it for therapeutic purpose [50]. More so, 
caution when taking ginger and other medicinal products needs to be 
taken because of apparent association of ginger with reported cases of 
increased risk of bleeding during surgery [51,52] or when taken with 
anticoagulant drugs such as warfarin [53].
Cuminum cyminum (cumin seed)
C. cyminum commonly known as cumin belongs to the family 
Apiaceae and the genus Cuminum. The seed of the plant is used as 
food additives/spice and for medicinal purpose. Cumin is cultivated 
in India, China, Middle East, and Mediterranean countries [54]. C. 
cyminun is reported to have antimicrobial [55], antidiabetic [56], 
anticancer [57], antioxidant [58], analgesic, anti-inflammatory [59], 
anti-hypertensive [60], and immunostimulatory [61] effects. In 
traditional medicine, cumin seeds are used for the treatment of 
diarrhea, headache, and stomach ache [62]. The bioactive compounds 
present in cumin are flavonoids, terpenes, and phenols [63]. These 
compounds provide the wide range of therapeutic benefits. Side effects 
of C. cyminum have not reported.
Allium cepa (onions)
A. cepa commonly known as onion is a vegetable crop that belongs to the 
family Liliaceae and genus Allium [64]. However, in recent taxonomic 
schemes, the A. cepa belongs to the family Amaryllidaceae [65]. It is 
grown in all parts of the world. The bulb is the part of the plant used for 
medicinal purpose and it is mostly included in food preparations. Onion 
has been reported to have several medicinal properties which include 
antioxidant, anti-inflammatory, antiviral, antifungal, and antiparasitic 
effects [66,67]. Bioactive compounds such as quercetin, myricetin, 
isorhamnetin, and kaempferol present in onion are reported to be 
responsible for the antiviral activity [68]. There are reports that onion 
is used for the treatment of diabetes, hypertension, and cardiovascular 
diseases [69-71]. Health risk of onions has not been reported.
CONCLUSION
Medicinal plants have great potential to be used for the treatment and 
prevention of COVID-19; however, there is a need for pre-clinical and 
clinical investigations of promising medicinal plants for their safety and 
efficacy.
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